
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
33,200 | 33,800 | 06.03. | |
33,200 | 33,800 | 06.03. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
27.02. | Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress | Submitted apitegromab U.S. Biologics License Application (BLA) for patients with spinal muscular atrophy in January 2025; U.S. launch anticipated in 4Q 2025
Remain on track to submit European Union... ► Artikel lesen | |
27.02. | Scholar Rock Holding Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
27.02. | Scholar Rock Holding Corp - 10-K, Annual Report | ||
27.02. | Scholar Rock Holding Corp - 8-K, Current Report | ||
25.02. | Truist maintains Scholar Rock buy rating, $45 target ahead of data |